Home »
Dermatology Therapeutics Market to 2017 - Alopecia Market is Forecast to Decline Due to Patent Expiry of Finasteride in 2013 and Weak Pipeline

Dermatology Therapeutics Market to 2017 - Alopecia Market is Forecast to Decline Due to Patent Expiry of Finasteride in 2013 and Weak Pipeline

Double click on above image to view full picture

Email to a Colleague - Print - Fax Order

Additional Information

Price	$3,500.00
Publisher	GBI Research
Date of Report	Jan 6, 2012

Add to Wishlist | Add to Compare

Qty:

-OR-

Quick Overview

Dermatology Therapeutics Market to 2017 - Alopecia Market is Forecast to Decline Due to Patent Expiry of Finasteride in 2013 and Weak Pipeline

Summary

GBI Research, the leading business intelligence provider, has released its latest research, “Dermatology Therapeutics Market to 2017 - Alopecia Market is Forecast to Decline Due to Patent Expiry of Finasteride in 2013 and Weak Pipeline”. It provides in-depth analysis of the unmet needs, drivers and barriers that affect the global dermatology therapeutics market. The report analyzes the markets for dermatology therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, revenue by geographical landscape for the indications covered in the report, and annual cost of treatment are forecast until 2017 for the key geographies and leading therapeutic segments. The report provides branded and generics segmentation in the therapeutic landscape segment. The report analyzes the competitive benchmarking for the leading companies and the mergers, acquisitions and licensing agreements that shape the global markets.

It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

GBI Research finds that the dermatology market will continue to grow at a steady CAGR during the period 2010–2017 compared to the CAGR during 2002–2010. The growth is primarily driven by the increase in the psoriasis market, which is attributed to increased competition among the existing products and a strong pipeline with more emerging therapies. Acne is the largest market segment, accounting for 28.7% of the total dermatology therapeutics market, followed by psoriasis (26.4%), rosacea (14.9%) and atopic dermatitis (9%). The global dermatology market is a highly fragmented market with large players facing tough competition. The forthcoming patent expiries of major drugs have increased the competition, further driving the consolidation. The increasing pressure has also driven companies to enter into licensing agreements to allow them to expand their product portfolio and improve competitive positions in the market.

Scope

- Annualized market data for the dermatology therapeutics market from 2002 to 2010, forecast forward to 2017.
- Analysis of the leading therapeutic segments. These include acne, psoriasis, atopic dermatitis, rosacea and herpes.
- Analysis of the dermatology therapeutics markets in the leading geographies of the world, which includes the US, the UK, Germany, France, Italy, Spain, and Japan.
- Market characterization of the dermatology therapeutics market including market size, annual cost of treatment, and treatment usage patterns.
- Key drivers and barriers that have a significant impact on the market.
- Coverage of pipeline molecules in various phases of drug development.
- Competitive benchmarking of leading companies. Key companies studied in this report are Centocor Ortho Biotech Inc, Amgen Inc, Abbott Laboratories, Merck & Co., Inc, Novartis AG and GlaxoSmithKline Plc.
- Key M&A activities and licensing agreements up to June 2011 in the global dermatology therapeutics market.

Reasons to buy

- Align your product portfolio to the markets with high growth potential.
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth.
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules with more efficiency and better safety.
- Develop key strategic initiatives by understanding the key focus areas of the leading companies.
- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps.

Table of Contents

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 7
2 Dermatology Therapeutics Market to 2017 - Introduction 9
2.1 Introduction 9
2.2 GBI Research Report Guidance 9
3 Dermatology Therapeutics Market to 2017 - Market Overview 10
3.1 Introduction 10
3.1.1 Annual Cost of Treatment 11
3.1.2 Treatment Usage Pattern 12
4 Dermatology Therapeutics Market to 2017 - Geographical Landscape 14
4.1 Geographical Break-up 14
4.2 The US 16
4.2.1 Revenue 16
4.2.2 Annual Cost of Treatment 17
4.2.3 Treatment Usage Pattern 18
4.3 Top Five Countries in Europe 20
4.3.1 Revenue 20
4.3.2 Annual Cost of Treatment 23
4.3.3 Treatment Usage Pattern 24
4.4 Japan 26
4.4.1 Revenue 26
4.4.2 Annual Cost of Treatment 27
4.4.3 Treatment Usage Pattern 28
5 Dermatology Therapeutics Market to 2017 - Therapeutic Landscape 30
5.1 Global Alopecia Therapeutics Market 30
5.1.1 Introduction 30
5.1.2 Revenue 32
5.1.3 Annual Cost of Treatment 35
5.1.4 Treatment Usage Pattern 36
5.1.5 Treatment Algorithm 38
5.1.6 Drivers and Restraints for the Alopecia Market 38
5.2 Global Herpes Therapeutics Market: Market Characterization 40
5.2.1 Introduction 40
5.2.2 Revenue 43
5.2.3 Annual Cost of Treatment 47
5.2.4 Treatment Usage Pattern 48
5.2.5 Treatment Algorithm 50
5.2.6 Drivers and Restraints for the Herpes Therapeutics Market 51
5.3 Global Psoriasis Therapeutics Market 52
5.3.1 Introduction 52
5.3.2 Revenue 53
5.3.3 Annual Cost of Treatment 56
5.3.4 Treatment Usage Pattern 57
5.3.5 Treatment Algorithm 59
5.3.6 Drivers and Restraints for Psoriasis Market 59
5.4 Global Acne Therapeutics Market 61
5.4.1 Introduction 61
5.4.2 Revenue 62
5.4.3 Annual Cost of Treatment 65
5.4.4 Treatment Usage Pattern 66
5.4.5 Treatment Algorithm 68
5.4.6 Drivers and Restraints for the Acne Therapeutics Market 68
5.5 Global Rosacea Disease Therapeutics Market 70
5.5.1 Introduction 70
5.5.2 Revenue 71
5.5.3 Annual Cost of Treatment 74
5.5.4 Treatment Usage Pattern 76
5.5.5 Treatment Algorithm 78
5.5.6 Drivers and Restraints for the Rosacea Therapeutics Market 79
5.6 Global Atopic Dermatitis Therapeutics Market 80
5.6.1 Introduction 80
5.6.2 Revenue 80
5.6.3 Annual Cost of Treatment 85
5.6.4 Treatment Usage Pattern 86
5.6.5 Treatment Algorithm 88
5.6.6 Drivers and Restraints for the Atopic Dermatitis Therapeutics Market 89
6 Dermatological Therapeutics Market to 2017 - Pipeline Analysis 91
6.1 Introduction 91
6.1.1 Research and Development Pipeline - Alopecia 92
6.1.2 Research and Development Pipeline - Herpes 93
6.1.3 Research and Development Pipeline - Psoriasis 95
6.1.4 Research and Development Pipeline - Acne 99
6.1.5 Research and Development Pipeline - Rosacea 101
6.1.6 Research and Development Pipeline - Atopic Dermatitis 102
6.2 Profiles of Promising Molecules in the Dermatology Therapeutics Market 105
6.2.1 LAS 41002 105
6.2.2 Duac Low Dose 106
6.2.3 Clindamycin + Tretinoin 107
7 Dermatology Therapeutics Market to 2017 - Competitive Landscape 108
7.1 Market Share Analysis - Dermatological Disorders 108
7.2 Competitive Profiling 109
7.2.1 Centocor Ortho Biotech Inc 109
7.2.2 Amgen 110
7.2.3 Abbott Laboratories 112
7.2.4 Merck & Co., Inc. 113
7.2.5 Novartis AG 115
7.2.6 GlaxoSmithKline plc. 116
8 Dermatology Therapeutics Market to 2017 - Strategic Consolidations 119
8.1 Mergers and Acquisitions 119
8.1.1 Deals by Indication 119
8.1.2 Deals by Geography 120
8.1.3 Deals by Value 121
8.1.4 Major M&A Deals 122
8.2 Licensing Agreements 123
8.2.1 Deals by Indication 123
8.2.2 Deals by Geography 124
8.2.3 Deals by Value 125
8.2.4 Major Licensing Agreements 126
9 Dermatology Therapeutics Market to 2017 - Appendix 127
9.1 Market Definitions 127
9.2 Abbreviations 127
9.3 Research Methodology 128
9.3.1 Coverage 128
9.3.2 Secondary Research 129
9.3.3 Primary Research 129
9.4 Therapeutic Landscape 130
9.4.2 Market Size by Geography 132
9.5 Geographical Landscape 133
9.6 Pipeline Analysis 133
9.7 Competitive Landscape 133
9.7.1 Expert Panel Validation 133
9.8 Contact Us 133
9.9 Disclaimer 133
9.10 Sources 134

1.1 List of Tables
Table 1: Dermatology Therapeutics Market, Global, Revenue ($bn), 2002-2010 10
Table 2: Dermatology Therapeutics Market, Global, Revenue Forecasts ($bn), 2010-2017 10
Table 3: Dermatology Therapeutics Market, Global, Annual Cost of Treatment ($), 2002-2010 11
Table 4: Dermatology Therapeutics Market, Global, Annual Cost of Treatment ($), 2010-2017 11
Table 5: Dermatology Therapeutics Market, Global, Treatment Usage Pattern (million), 2002-2010 12
Table 6: Dermatology Therapeutics Market, Global, Treatment Usage Pattern (million), 2010-2017 13
Table 7: Dermatology Therapeutics Market, Revenue by Geography ($m), 2002-2010 14
Table 8: Dermatology Therapeutics Market, Revenue by Geography ($m), 2010-2017 15
Table 9: Dermatology Therapeutics Market, The US, Revenue ($m), 2002-2010 16
Table 10: Dermatology Therapeutics Market, The US, Revenue Forecasts ($m), 2010-2017 16
Table 11: Dermatology Therapeutics Market, The US, Annual Cost of Treatment ($), 2002-2010 17
Table 12: Dermatology Therapeutics Market, The US, Annual Cost of Treatment ($), 2010-2017 17
Table 13: Dermatology Therapeutics Market, The US, Treatment Usage Pattern (million), 2002-2010 18
Table 14: Dermatology Therapeutics Market, The US, Treatment Usage Pattern (million), 2010-2017 19
Table 15: Dermatology Therapeutics Market, Top Five Countries in Europe, Revenue ($m), 2002-2010 20
Table 16: Dermatology Therapeutics Market, Top Five Countries in Europe, Revenue Forecasts ($m), 2010-2017 20
Table 17: Dermatology Therapeutics Market, Top Five Countries in Europe, Revenue by Country ($m), 2002-2010 21
Table 18: Dermatology Therapeutics Market, Top Five Countries in Europe, Revenue by Country ($m), 2010-2017 22
Table 19: Dermatology Therapeutics Market, Top Five Countries in Europe, Annual Cost of Treatment ($), 2002-2010 23
Table 20: Dermatology Therapeutics Market, Top Five Countries in Europe, Annual Cost of Treatment ($), 2010-2017 23
Table 21: Dermatology Therapeutics Market, Top Five Countries in Europe, Treatment Usage Pattern (million), 2002-2010 24
Table 22: Dermatology Therapeutics Market, Top Five Countries in Europe, Treatment Usage Pattern (million), 2010-2017 25
Table 23: Dermatology Therapeutics Market, Japan, Revenue ($m), 2002-2010 26
Table 24: Dermatology Therapeutics Market, Japan, Revenue Forecasts ($m), 2010-2017 26
Table 25: Dermatology Therapeutics Market, Japan, Annual Cost of Treatment ($), 2002-2010 27
Table 26: Dermatology Therapeutics Market, Japan, Annual Cost of Treatment ($), 2010-2017 27
Table 27: Dermatology Therapeutics Market, Japan, Treatment Usage Pattern (million), 2002-2010 28
Table 28: Dermatology Therapeutics Market, Japan, Treatment Usage Pattern (million), 2010-2017 29
Table 29: Alopecia Therapeutics Market, Global, Revenue ($bn), 2002-2010 32
Table 30: Alopecia Therapeutics Market, Global, Revenue Forecasts ($bn), 2010-2017 32
Table 31: Alopecia Therapeutics Market, Global, Revenue by Geography ($m), 2002-2010 33
Table 32: Alopecia Therapeutics Market, Global, Revenue by Geography ($m), 2010-2017 33
Table 33: Alopecia Therapeutics Market, Global, Annual Cost of Treatment($), 2002-2010 35
Table 34: Alopecia Therapeutics Market, Global, Annual Cost of Treatment($), 2010-2017 35
Table 35: Alopecia Therapeutics Market, Global, Treatment Usage Pattern (million), 2002-2010 36
Table 36: Alopecia Therapeutics Market, Global, Treatment Usage Pattern (million), 2010-2017 37
Table 37: Herpes Therapeutics Market, Global, Revenue ($bn), 2002-2010 43
Table 38: Herpes Therapeutics Market, Global, Revenue Forecasts ($bn), 2002-2017 43
Table 39: Herpes Therapeutics Market, Global, Revenue by Geography ($m), 2002-2010 44
Table 40: Herpes Therapeutics Market, Global, Revenue by Geography ($m), 2010-2017 45
Table 41: Herpes Therapeutics Market, Global, Annual Cost of Treatment ($), 2002-2010 47
Table 42: Herpes Therapeutics Market, Global, Annual Cost of Treatment ($), 2010-2017 47
Table 43: Herpes Therapeutics Market, Global, Treatment Usage Pattern (million), 2002-2010 48
Table 44: Herpes Therapeutics Market, Global, Treatment Usage Pattern (million), 2010-2017 49
Table 45: Psoriasis Therapeutics Market, Global, Revenue ($bn), 2002-2010 53
Table 46: Psoriasis Therapeutics Market, Global, Revenue Forecasts ($bn), 2010-2017 53
Table 47: Psoriasis Therapeutics Market, Global, Revenue by Geography ($m), 2002-2010 54
Table 48: Psoriasis Therapeutics Market, Global, Revenue by Geography ($m), 2010-2017 55
Table 49: Psoriasis Therapeutics Market, Global, Annual Cost of Treatment ($), 2002-2010 56
Table 50: Psoriasis Therapeutics Market, Global, Annual Cost of Treatment ($), 2010-2017 56
Table 51: Psoriasis Therapeutics Market, Global, Treatment Usage Pattern (million), 2002-2010 57
Table 52: Psoriasis Therapeutics Market, Global, Treatment Usage Pattern (million), 2010-2017 58
Table 53: Acne Therapeutics Market, Global, Revenue ($bn), 2002-2010 62
Table 54: Acne Therapeutics Market, Global, Revenue Forecasts ($bn), 2010-2017 62
Table 55: Acne Therapeutics Market, Global, Revenue by Geography ($m), 2002-2010 63
Table 56: Acne Therapeutics Market, Global, Revenue by Geography ($m), 2010-2017 64
Table 57: Acne Therapeutics Market, Global, Annual Cost of Treatment ($), 2002-2010 65
Table 58: Acne Therapeutics Market, Global, Annual Cost of Treatment ($), 2010-2017 65
Table 59: Acne Therapeutics Market, Global, Treatment Usage Pattern (million), 2002-2010 66
Table 60: Acne Therapeutics Market, Global, Treatment Usage Pattern (million), 2010-2017 67
Table 61: Rosacea Therapeutics Market, Global, Revenue ($bn), 2002-2010 71
Table 62: Rosacea Therapeutics Market, Global, Revenue Forecasts ($bn), 2010-2017 71
Table 63: Rosacea Therapeutics Market, Global, Revenue Analysis by Geography ($m), 2002-2010 72
Table 64: Rosacea Therapeutics Market, Global, Revenue Analysis by Geography ($m), 2010-2017 73
Table 65: Rosacea Therapeutics Market, Global, Annual Cost of Treatment, ($) 2002-2010 74
Table 66: Rosacea Therapeutics Market, Global, Annual Cost of Treatment ($), 2010-2017 74
Table 67: Rosacea Therapeutics Market, Global, Treatment Usage Pattern (million), 2002-2010 76
Table 68: Rosacea Therapeutics Market, Global, Treatment Usage Pattern (million), 2010-2017 77
Table 69: Atopic Dermatitis Therapeutics Market, Global, Revenue ($m), 2002-2010 81
Table 70: Atopic Dermatitis Therapeutics Market, Global, Revenue Forecasts ($m), 2010-2017 81
Table 71: Atopic Dermatitis Therapeutics Market, Global, Revenue Analysis by Geography ($m), 2002-2010 82
Table 72: Atopic Dermatitis Therapeutics Market, Global, Revenue Analysis by Geography ($m), 2010-2017 83
Table 73: Atopic Dermatitis Therapeutics Market, Global, Annual Cost of Treatment ($), 2002-2010 85
Table 74: Atopic Dermatitis Therapeutics Market, Global, Annual Cost of Treatment ($), 2010-2017 85
Table 75: Atopic Dermatitis Therapeutics Market, Global, Treatment Usage Pattern (million), 2002-2010 86
Table 76: Atopic Dermatitis Therapeutics Market, Global, Treatment Usage Pattern (million), 2010-2017 87
Table 77: Alopecia Therapeutics Market, Global, Pipeline Analysis, Phase II, May 2011 92
Table 78: Alopecia Therapeutics Market, Global, Pipeline Analysis, Preclinical, May 2011 92
Table 79: Herpes Therapeutics Market, Global, Pipeline Analysis, Phase III, May 2011 93
Table 80: Herpes Therapeutics Market, Global, Pipeline Analysis, Phase II, May 2011 93
Table 81: Herpes Therapeutics Market, Global, Pipeline Analysis, Phase I, May 2011 94
Table 82: Herpes Therapeutics Market, Global, Pipeline Analysis, Preclinical, May 2011 94
Table 83: Psoriasis Therapeutics Market, Global, Pipeline Analysis, NDA Filed, May 2011 95
Table 84: Psoriasis Therapeutics Market, Global, Pipeline Analysis, Phase III, May 2011 95
Table 85: Psoriasis Therapeutics Market, Global, Pipeline Analysis, Phase II, May 2011 96
Table 86: Psoriasis Therapeutics Market, Global, Pipeline Analysis, Phase I, May 2011 97
Table 87: Psoriasis Therapeutics Market, Global, Pipeline Analysis, Preclinical, May 2011 98
Table 88: Acne Therapeutics Market, Global, Pipeline Analysis, NDA Filed, May 2011 99
Table 89: Acne Therapeutics Market, Global, Pipeline Analysis, Phase III, May 2011 99
Table 90: Acne Therapeutics Market, Global, Pipeline Analysis, Phase II, May 2011 100
Table 91: Acne Therapeutics Market, Global, Pipeline Analysis, Phase I, May 2011 100
Table 92: Acne Therapeutics Market, Global, Pipeline Analysis, Preclinical, May 2011 101
Table 93: Rosacea Therapeutics Market, Global, Pipeline Analysis, Phase III, May 2011 101
Table 94: Rosacea Therapeutics Market, Global, Pipeline Analysis, Phase II, May 2011 102
Table 95: Rosacea Therapeutics Market, Global, Pipeline Analysis, Phase I, May 2011 102
Table 96: Rosacea Therapeutics Market, Global, Pipeline Analysis, Preclinical, May 2011 102
Table 97: Atopic Dermatitis Therapeutics Market, Global, Pipeline Analysis, NDA Filed, May 2011 102
Table 98: Atopic Dermatitis Therapeutics Market, Global, Pipeline Analysis, Phase III, May 2011 103
Table 99: Atopic Dermatitis Therapeutics Market, Global, Pipeline Analysis, Phase II, May 2011 103
Table 100:Atopic Dermatitis Therapeutics Market, Global, Pipeline Analysis, Phase I, May 2011 104
Table 101:Atopic Dermatitis Therapeutics Market, Global, Pipeline Analysis, Preclinica, May 2011 104

1.2 List of Figures
Figure 1: Dermatology Therapeutics Market, Global, Revenue Forecasts ($bn), 2002-2017 10
Figure 2: Dermatology Therapeutics Market, Global, Annual Cost of Treatment ($), 2002-2017 11
Figure 3: Dermatology Therapeutics Market, Global, Treatment Usage Pattern (million), 2002-2017 12
Figure 4: Dermatology Therapeutics Market, Revenue by Geography ($m), 2002-2017 14
Figure 5: Dermatology Therapeutics Market, The US, Revenue Forecasts ($m), 2002-2017 16
Figure 6: Dermatology Therapeutics Market, The US, Annual Cost of Treatment ($), 2002-2017 17
Figure 7: Dermatology Therapeutics Market, The US, Treatment Usage Pattern (million), 2002-2017 18
Figure 8: Dermatology Therapeutics Market, Top Five Countries in Europe, Revenue Forecasts ($m), 2002-2017 20
Figure 9: Dermatology Therapeutics Market, Top Five Countries in Europe, Revenue by Country ($m), 2002-2017 21
Figure 10: Dermatology Therapeutics Market, Top Five Countries in Europe, Annual Cost of Treatment ($), 2002-2017 23
Figure 11: Dermatology Therapeutics Market, Top Five Countries in Europe, Treatment Usage Pattern (million), 2002-2017 24
Figure 12: Dermatology Therapeutics Market, Japan, Revenue Forecasts ($m), 2002-2017 26
Figure 13: Dermatology Therapeutics Market, Japan, Annual Cost of Treatment ($), 2002-2017 27
Figure 14: Dermatology Therapeutics Market, Japan, Treatment Usage Pattern (million), 2002-2017 28
Figure 15: Alopecia Therapeutics Market, Global, Revenue Forecasts ($bn), 2002-2017 32
Figure 16: Alopecia Therapeutics Market, Global, Revenue by Geography ($m), 2002-2017 33
Figure 17: Alopecia Therapeutics Market, Global, Revenue Segmentation, 2010 and 2017 34
Figure 18: Alopecia Therapeutics Market, Global, Annual Cost of Treatment ($), 2002-2017 35
Figure 19: Alopecia Therapeutics Market, Global, Treatment Usage Pattern (million), 2002-2017 36
Figure 20: Alopecia Therapeutics Market, Global, Treatment Algorithm 38
Figure 21: Alopecia Therapeutics Market, Drivers and Barriers. 2010-2017 39
Figure 22: Herpes Therapeutics Market, Global, Revenue Forecasts ($bn), 2002-2017 43
Figure 23: Herpes Therapeutics Market, Global, Revenue by Geography ($m), 2002-2017 44
Figure 24: Herpes Therapeutics Market, Global, Revenue Segmentation, 2010 and 2017 46
Figure 25: Herpes Therapeutics Market, Global, Annual Cost of Treatment ($), 2002-2017 47
Figure 26: Herpes Therapeutics Market, Global, Treatment Usage Pattern (million), 2002-2017 48
Figure 27: Herpes Therapeutics Market, Global, Treatment Algorithm 50
Figure 28: Herpes Therapeutics Market, Drivers and Barriers, 2010-2017 51
Figure 29: Psoriasis Therapeutics Market, Global, Revenue Forecasts ($bn), 2002-2017 53
Figure 30: Psoriasis Therapeutics Market, Global, Revenue by Geography ($m), 2002-2017 54
Figure 31: Psoriasis Therapeutics Market, Global, Revenue Segmentation, 2010 and 2017 55
Figure 32: Psoriasis Therapeutics Market, Global, Annual Cost of Treatment ($), 2002-2017 56
Figure 33: Psoriasis Therapeutics Market, Global, Treatment Usage Pattern (million), 2002-2017 57
Figure 34: Psoriasis Therapeutics Market, Global, Treatment Algorithm 59
Figure 35: Psoriasis Therapeutics Market, Drivers and Barriers, 2010-2017 60
Figure 36: Acne Therapeutics Market, Global, Revenue Forecasts ($bn), 2002-2017 62
Figure 37: Acne Therapeutics Market, Global, Revenue by Geography ($m), 2002-2017 63
Figure 38: Acne Therapeutics Market, Global, Revenue Segmentation, 2010 and 2017 64
Figure 39: Acne Therapeutics Market, Global, Annual Cost of Treatment ($), 2002-2017 65
Figure 40: Acne Therapeutics Market, Global, Treatment Usage Pattern (million), 2002-2017 66
Figure 41: Acne Therapeutics Market, Global, Treatment Algorithm 68
Figure 42: Acne Therapeutics Market, Drivers and Barriers, 2010-2017 69
Figure 43: Rosacea Therapeutics Market, Global, Revenue Forecasts ($bn), 2002-2017 71
Figure 44: Rosacea Therapeutics Market, Global, Revenue Analysis by Geography ($m), 2002-2017 72
Figure 45: Rosacea Therapeutics Market, Global, Revenue Segmentation, 2010 and 2017 73
Figure 46: Rosacea Therapeutics Market, Global, Annual Cost of Treatment ($), 2002-2017 74
Figure 47: Rosacea Therapeutics Market, Global, Treatment Usage Pattern (million), 2002-2017 76
Figure 48: Rosacea Therapeutics Market, Global, Treatment Algorithm 78
Figure 49: Rosacea Therapeutics Market, Drivers and Barriers, 2010-2017 79
Figure 50: Atopic Dermatitis Therapeutics Market, Global, Revenue Forecasts ($m), 2002-2017 80
Figure 51: Atopic Dermatitis Therapeutics Market, Global, Revenue Analysis by Geography ($m), 2002-2017 82
Figure 52: Atopic Dermatitis Therapeutics Market, Global, Revenue Segmentation, 2010 and 2017 84
Figure 53: Atopic Dermatitis Therapeutics Market, Global, Annual Cost of Treatment ($), 2002-2017 85
Figure 54: Atopic Dermatitis Therapeutics Market, Global, Treatment Usage Pattern (million), 2002-2017 86
Figure 55: Atopic Dermatitis Therapeutics Market, Global, Treatment Algorithm 88
Figure 56: Atopic Dermatitis Therapeutics Market, Drivers and Barriers, 2010-2017 89
Figure 57: Dermatological Disorders Therapeutics Market, Global, R&D Pipeline by Indication (%), 2011 91
Figure 58: Dermatology Market, Global, Market Share of Top Manufacturers, Jun 2011 108
Figure 59: Dermatology Therapeutics Market, Global, SWOT - Centocor Ortho Biotech Inc, 2010 110
Figure 60: Dermatology Therapeutics Market, Global, SWOT - Amgen, 2010 111
Figure 61: Dermatology Therapeutics Market, Global, SWOT - Abbott Laboratories, 2010 113
Figure 62: Dermatology Therapeutics Market, Global, SWOT - Merck, 2010 114
Figure 63: Dermatology Therapeutics Market, Global, SWOT - Novartis AG, 2010 116
Figure 64: Dermatology Therapeutics Market, Global, SWOT - GlaxoSmithKline, 2010 118
Figure 65: Dermatological Disorders Therapeutics Market, M&A Deals by Indication (%), Jun 2011 119
Figure 66: Dermatology Therapeutics Market, Major Deals by Geography (%), Jun 2011 120
Figure 67: Dermatological Disorders Therapeutics Market, Deals by Value (%), Jun 2011 121
Figure 68: Dermatology Therapeutics Market, Global, Licensing Agreements by Indication, Jun 2011 123
Figure 69: Dermatological Therapeutics Market, Global, Licensing Agreements by Geography, Jun 2011 124
Figure 70: Dermatological Disorders Therapeutics Market, Major Licensing Agreements by Deal Value (%), Jun 2011 125
Figure 71: GBI Research Market Forecasting Model 132